Steroid sulfatase: Molecular biology, regulation, and inhibition

Endocrine Reviews

Volumn 26, Issue 2, 2005, Pages 171-202

  Reed, M J ^a   Purohit, A ^a   Woo, L W L ^b   Newman, S P ^a   Potter, B V L ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

(4 O SULFAMOYL) N TETRADECANOYLTYRAMINE; 17ALPHA BENZYLESTRADIOL; 17ALPHA TERT BUTYLBENZYL 5 ANDROSTEN 17BETA OL; 2 (HYDROXYPHENYL)INDOLE SULFATE; 4 METHYLCOUMARIN 7 O SULFAMATE; 6 OXO 8,9,10,11 TETRAHYDRO 7H CYCLOHEPTA[C][1]BENZOPYRAN 3 O SULFAMATE; AMIDE; ANDROSTENEDIOL; ANDROSTENEDIOL SULFATE; COUMARIN DERIVATIVE; DAIDZEIN 4' O SULFATE; DAIDZEIN 4',7 DI O SULFATE; ENZYME INHIBITOR; ESTER; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRONE; ESTRONE 3 O SULFAMATE; ESTRONE DERIVATIVE; ESTRONE SULFATE; FLAVONOID; PHENOL SULFAMATE ESTER; PRASTERONE; PRASTERONE SULFATE; STEROID SULFATASE INHIBITOR; STERYL SULFATASE; UNCLASSIFIED DRUG;

BREAST CANCER; BREAST TUMOR; CLINICAL TRIAL; CRYSTAL STRUCTURE; DRUG POTENCY; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN ACTIVITY; HORMONE DEPENDENCE; HUMAN; HYDROLYSIS; IMMUNOCYTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE TUMOR; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; BREAST NEOPLASMS; CLINICAL TRIALS, PHASE I; COUMARINS; ENZYME INHIBITORS; ESTRONE; FEMALE; HUMANS; MODELS, MOLECULAR; NEOPLASMS, HORMONE-DEPENDENT; STERYL-SULFATASE; SULFONAMIDES;

EID: 17044428337     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2004-0003     Document Type: Review

References (318)

1. Schacter B, Marrian GF 1938 The isolation of estrone sulfate from the urine of pregnant mares. J Biol Chem 126:663-669
2. Bond CS, Clements PR, Ashby SJ, Collyer CA, Harrop SJ, Hopwood JJ, Guss JM 1997 Structure of a human lysosomal sulfatase. Structure 5:277-289
3. Ferrante P, Messali S, Meroni G, Ballabio A 2002 Molecular and biochemical characterisation of a novel sulphatase gene: aryl sulphatase G (ARSG). Eur J Hum Genet 10:813-818
4. Yen PH, Marsh B, Allen E, Tsai SP, Ellison J, Connoly L, Neiswanger K, Shapiro LJ 1988 The human X-linked steroid sulfatase gene and a Y-encoded pseudogene: evidence for an inversion of the Y chromosome during primate evolution. Cell 55:1123-1135
5. Yen PH, Allen E, Marsh B, Mohandas T, Wang N, Taggart, Shapiro LJ 1987 Cloning and expression of the steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell 49:443-454
6. Stein C, Hille A, Seidel J, Rijnbout S, Waheed A, Schmidt B, Geuze H, von Figura K 1989 Cloning and expression of human steroid-sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21 cells. J Biol Chem 264:13865-13872
7. Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T 1989 Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA 86:8477-8481
8. Basler E, Grompe M, Parenti G, Yates J, Ballabio A 1992 Identification of point mutations in the steroid sulfatase gene of three patients with X-linked ichthyosis. Am J Hum Genet 50:483-491
9. Alperin ES, Shapiro LJ 1997 Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and function of the steroid sulfatase protein. J Biol Chem 272:20756-20763
10. Valdes-Flores M, Vaca ALJ, Kofman-Alfaro SH, Cuevas-Covarrubias SA 2001 Characterization of a novel point mutation (Arg432His) in X-linked ichthyosis. Acta Derm Venereol 81:54-78
11. Gonzalez-Huerta LM, Riviera-Vega MR, Kofman-Alfeuro SH, Cuevas-Covarrubias SA 2003 Novel missense mutation (Arg432Cys) in a patient with steroid sulphatase-deficiency. Clin Endocrinol (Oxf) 59: 263-265
12. Peters C, Schmidt B, Rommerskirch W, Rupp K, Zuhlsdorf M, Vingron M, Meyer HE, Pohlmann R, von Figura K 1990 Phylogenetic conservation of arylsulfatases. cDNA cloning and expression of human arylsulfatase B. J Biol Chem 265:3374-3381
13. Newman SP, Purohit A, Ghilchik MW, Potter BVL, Reed MJ 2000 Regulation of steroid sulphatase expression and activity in breast cancer. J Steroid Biochem Mol Biol 75:259-264
14. Li X-M, Alperin ES, Salido E, Gong Y, Yen P, Shapiro LJ 1996 Characterization of the promoter of human steroid suifatase: a gene which escapes X inactivation. Somat Cell Mol Genet 22:105-117
15. Dodgson KS, Spencer B, Thomas J 1954 Studies on sulphatases. 6. The localization of arylsulphatase in the rat-liver cell. J Biochem 56:177-181
16. Partanen S 1985 Histochemistry of estrogen sulfatases in human breast diseases. Virchows Arch (Cell Pathol) 49:53-60
17. Willemsen R, Kroos M, Hoogeveen AT, van Dongen JM, Parenti G, Van Der Loos CM, Reuser AJJ 1988 Ultrastructural localization of steroid sulphatase in cultured human fibroblasts by immunocytochemistry: a comparative study with lysosomal enzymes and the mannose-6-phoshphate receptor. Histochem J 20:41-51
18. Kawano J-I, Kotani T, Umeki K, Oinuma T, Ohtaki S, Aikawa E 1989 A monoclonal antibody to rat liver arylsulfatase C and its application in immunohistochemistry. J Histochem Cytochem 37: 683-690
19. Okuda T, Saito H, Sekizawa A, Shimizu Y, Akamatsu T, Kushima M, Yanaihara T, Okai T, Farina A 2001 Steroid sulfatase expression in ovarian clear cell adenocarcinoma: immunohistochemical study. Gynecol Oncol 82:427-434
20. Ezaki K, Motoyama H, Sasaki H 2001 Immunohistologic localization of estrone sulfatase in uterine endometrium and adenomyosis. Obstet Gynecol 98:815-819
21. Nakamura Y, Miki Y, Susuki T, Nakata T, Darnel AD, Mariya T, Tazawa C, Saito H, Ishibashi TST, Yamada S, Sasano H 2003 Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta. Am J Pathol 163:1329-1339
22. Yanaihara A, Yanaihara T, Toma Y, Shimizu Y, Saito H, Okai T, Higashiyama T, Osawa Y 2001 Localization and expression of steroid sulfatase in human fallopian tubes. Steroids 66:87-91
23. Miki Y, Nakata T, Suzuki T, Darnel AD, Moriya T, Kaneko C, Hidaka K, Shiotsu Y, Kusaka H, Sasano H 2002 Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 87:5760-5768
24. Suzuki T, Nakata T, Miki Y, Kaneko C, Moriya T, Ishida T, Akinaga S, Hirakawa H, Kimura M, Sasano H 2003 Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 63:2762-2770
25. 3H-3β-hydroxy androst-5-en-17-one sulfate. J Biol Chem 238:1656-1660
26. Han HD, Fencl MM, Tulchinsky D 1987 Variations in estrone sulfatase activity in human leukocytes. J Clin Endocrinol Metab 65:1026-1030
27. Iwamori M, Moser HW, Kishimoto Y 1976 Steroid sulfatase in brain: comparison of sulfohydrolase activities for various steroid sulfates in normal and pathological brains, including the various forms of metachromatic leukodystrophy. J Neurochem 27:1389-1395
28. Kishimoto Y, Sostek R 1972 Activity of sterol-sulphate sulphohydrolase in rat brain: characterization, localization and change with age. J Neurochem 19:123-130
29. Purohit A, Flanagan AM, Reed MJ 1992 Estrogen synthesis by osteoblast cell lines. Endocrinology 131:2027-2029
30. Fujikawa H, Okura F, Kuwano Y, Sekizawa A, Chiba H, Shimodaira K, Saito H, Yanaihara T 1997 Steroid sulfatase activity in osteoblast cells. Biochem Biophys Res Commun 231:42-47
31. Clemens JW, Kahler HL, Sarrap JL, Beyer AR, Li P-K, Selcer KW 2000 Steroid sulfatase activity in the rat ovary, cultured granulosa cells and a granulosa cell line. J Steroid Biochem Mol Biol 75:245-252
32. Bonser J, Walker J, Purohit A, Reed MJ, Potter BVL, Willis DS, Franks S, Mason HD 2000 Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production. J Endocrinol 167:465-471
33. Payne AH, Mason M, Jaffe RB 1969 Testicular steroid sulfatase: substrate specificity and inhibition. Steroids 14:685-704
34. Meyer CH, Grundmann H, Weiss H 1984 Steroid sulfatase = Arylsulfatase C? Chromatographic and electrophoretic properties in extracts from placental microsomes and skin fibroblasts. Dermatologica 169:305-310
35. Burns GRJ 1983 Purification and partial characterisation of arylsulphatase C from human placental microsomes. Biochim Biophys Acta 759:199-204
36. Noel H, Plante L, Bleau G, Chapdelaine A, Roberts KI 1983 Human placental steroid sulfatase: purification and properties. J Steroid Biochem 19:1591-1598
37. Egyed J, Oakey RE 1985 Hydrolysis of deoxycorticosterone-21-yl sulphate and dehydroepiandrosterone sulphate by microsomal preparations of human placenta: evidence for a common enzyme. J Endocrinol 106:295-301
38. Dibbelt L, Kuss E 1983 Human placental steroid sulfatase. Hoppe-Seylers Z Physiol Chem 364:187-191
39. Rester MHA, Kaptein E, Van Dijk CH, Roest TJ, Tibbod D, Coughtrie MWH, Visser TJ 2002 Characterisation of iodothyronine sulfatase activities in human and rat liver and placenta. Endocrinology 143:814-819
40. Jobsis AC, de Groot WP, Tigges AJ, de Bruijn HW, Rijken Y, Meijer AE, Marinkovic-Ilsen A 1980 X-linked ichthyosis and X-linked placental sulfatase deficiency: a disease entity. Histochemical observations. Am J Pathol 99:279-289
41. Epstein EH, Benifas JM 1985 Recessive X-linked ichthyosis: lack of immunologically detectable steroid sulfatase enzyme protein. Hum Genet 71:201-205
42. Shapiro LJ, Cousins L, Fluharry AL, Stevens RL, Kihara H 1977 Steroid sulfatase deficiency. Pediatr Res 11:894-897
43. Lykkesfeldt G 1987 Human steroid sulphatase deficiency: clinical, endocrinology and genetic aspects. Dan Med Bull 34:69-83
44. Purohit A, Dauvois S, Parker MG, Potter BVL, Williams GJ, Reed MJ 1994 The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells. J Steroid Biochem Mol Biol 50:101-104
45. Nelson K, Keinanen BM, Daniel WL 1983 Murine arylsulfatase C: evidence for two isozymes. Experientia 39:740-742
46. Zhu BT, Fu J-H, Xu S, Kauffman FC, Conney AH 1998 Different biochemical properties of nuclear and microsomal estrone-3-sulfatases: evidence for the presence of a nuclear isozyme. Biochem Biophys Res Commun 246:45-49
47. Gniot-Szulzycka J, Januszewska B 1986 Purifcation of steroid sulphohydrolase from human placenta microsomes. Acta Biochim Pol 33:203-215
48. Simard JP, Ameen M, Chang PL 1985 Biochemical characterisation of arylsulfatase-C isozymes in human fibroblasts. Biochem Biophys Res Commun 128:1388-1394
49. Chang PL, Mueller OT, Lafrenie RM, Varey PA, Rosa NE, Davidson RG, Henry WM, Shows TB 1990 The human arylsulfatase C isoenzymes: two distinct genes that escape from inactivation. Am J Hum Genet 46:729-737
50. Munroe DG, Chang PL 1987 Tissue-specific expression of human arylsulfatase C isozymes and steroid sulfatase. Am J Hum Genet 40:102-114
51. Purohit A, Reed MJ, Morris NC, Williams GJ, Potter BVL 1996 Regulation and inhibition of steroid sulfatase activity in breast cancer. Ann NY Acad Sci 784:40-49
52. Ptirohit A, Duncan LJ, Wang DY, Coldham NG, Ghilchik MW, Reed MJ 1997. Paracrine control of oestrogen production in breast cancer. Endocr Rel Cancer 4:323-330
53. Matsuoka R, Yanaihara A, Saito H, Furusawa Y, Toma Y, Shimizu Y, Yanaihara T, Okai T 2002 Regulation of estrogen activity in human endometrium: effect of IL-1β on steroid sulfatase activity in human endometrial stromal cells. Steroids 67:655-659
54. Purohit A, Budai B, Wang DY, Willemsen EL, de Winkel A, Parish D, Ghilchik MW, Szamel I, Reed MJ 2000 Modulation of oestrone sulphate formation and hydrolysis in breast cancer cells by breast cyst fluid from British and Hungarian women. Br J Cancer 82:492-496
55. Purohit A, Chapman O, Duncan L, Reed MJ 1992 Modulation of oestrone sulphatase activity in breast cancer cell lines by growth factors. J Steroid Biochem Mol Biol 41:563-566
56. Schneider G, French A, Bullock LP, Bardin CW 1971 Absence of androgen stimulation of hepatic steroid sulfatase in the female rat. Endocrinology 89:308-310
57. Lam STS, Polani PE 1985 Hormonal induction of steroid sulphatase in the mouse. Experientia 41:276-278
58. Moutaouakkil M, Prost O, Dahan N, Adessi GL 1984 Estrone and dehydroepiandrosterone sulfatase activities in guinea-pig uterus and liver: estrogenic effect of estrone sulfate. J Steroid Biochem 21:321-328
59. Berth A, Romer W, Oettel M 2000 Influence of subchronic administration of oestrone-3-O-sulphamate on oestrone sulphatase activity in liver, spleen and white blood cells of ovariectomised rats. Arch Toxicol 74:366-371
60. Pasqualini JR, Maloche C, Maroni M, Chetrite G 1994 Effect of the progestagen Promegestone (R-5020) on mRNA of the oestrone sulphatase in the MCF-7 human mammary cancer cells. Anticancer Res 14:1589-1594
61. Purohit A, Reed MJ 1992 Oestrogen sulphatase activity in hormone-dependent and hormone-independent breast cancer cells: modulation by steroidal and non-steroidal therapeutic agents. Int J Cancer 50:901-905
62. Beck L, Mahfoudi A, Mularoni A, Nicollier M, Adessi GL 1992 Progesterone stimulates sulfate uptake in subcultured endometrial epithelial cells. Mol Cell Endocrinol 90:95-102
63. 3. Biochem J 355:361-371
64. James VHT, Reed MJ 1980 Steroid hormones and human cancer. Prog Cancer Res Therapy 14:471-487
65. Bernstein L, Ross RK 1993 Endogenous hormones and breast cancer. Epidemiol Rev 15:48-65
66. MacDonald PC, Edman CD, Hemsell DL, Porter JC, Siiteri PK 1978 Effect of obesity on conversion of plasma androstenedione to estrone in women with and without endometrial cancer. Am J Obstet Gynecol 130:448-455
67. Reed MJ, Button JD, Baxendale PM, James VHT, Jacobs HS, Fisher RP 1979 The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer. J Steroid Biochem 11:905-911
68. rd ed. London: Academic Press; 263-353
69. Hobkirk R 1993 Steroid sulfation. Trends Endocrinol Metab 4:69-74
70. Falany JL, Falany CN 1996 Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56:1551-1555
71. Falany JL, Macrina N, Falany CN 2002 Regulation of MCF-7 breast cancer cell growth by β-estradiol sulfonation. Breast Cancer Res Treat 74:167-176
72. Strott CA 2002 Sulfonation and molecular action. Endocr Rev 23: 703-732
73. Noel CT, Reed MJ, Jacobs HS, James VHT 1981 The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight. J Steroid Biochem 14:1101-1105
74. Pasqualini JR, Gelly C, Nguyen BL, Vella C 1989 Importance of oestrogen sulfates in breast cancer. J Steroid Biochem 34:155-163
75. Ruder HJ, Loriaux DL, Lipsett MB 1972 Estrone sulfate: production rate and metabolism in man. J Clin Invest 51:1020-1033
76. Reed MJ, Purohit A1993 Sulphatase inhibitors: the rationale for the development of a new endocrine therapy. Rev Endocr Rel Cancer 45:51-62
77. Reed MJ, Purohit A 1994 Inhibition of steroid sulphatases. In: Sandier M, Smith HJ, eds. Design of enzyme inhibitors as drugs, vol. 2. Oxford: Oxford University Press; 481-494
78. Reed MJ, Purohit A, Howarth NM, Potter BVL 1994 Steroid sulphatase inhibitors: a new endocrine therapy. Drugs Future 19:673-680
79. Reed MJ, Purohit A, Woo LWL, Potter BVL 1996 The development of steroid sulphatase inhibitors. Endocr Rel Cancer 3:9-23
80. Bonney RC, Reed MJ, Davidson K, Beranek PA, James VHT1983 The relationship between 17β hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin Endocrinol (Oxf) 19:727-739
81. Van Landeghem AAJ, Poortman J, Nabuurs M, Thijssen JHH 1985 Endogenous concentrations and sub-cellular distribution of estrogens in normal and malignant breast tissue. Cancer Res 45: 2900-2904
82. Thijssen JHH, Blankenstein MA, Miller WR, Milewicz A 1987 Estrogens in tissues: uptake from the peripheral circulation or local production. Steroids 50:297-306
83. Thijssen JHH, Blankenstein MA 1989 Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues. Eur J Cancer Clin Oncol 25:1953-1959
84. Fishman J, Nisselbaum JS, Menendez-Botet CJ, Schwartz MK 1977 Estrone and estradiol content in human breast tumours: relationship to estradiol receptors. J Steroid Biochem 8:893-896
85. Edery M, Goussard J, Dehennin L, Scholler R, Reiffsteck J, Drosdowsky MA 1981 Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur J Cancer 17:115-120
86. James VHT, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ 1987 Aromatase activity in normal breast and breast tumor tissue: in vivo and in vitro studies. Steroids 50:269-279
87. Yamamoto T, Kitawaki J, Urabe M, Honjo H, Tamra T, Noguchi T, Okada H, Sasaki H, Tada A, Terashima Y, Nakamura J, Yoshihama M 1993 Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells. J Steroid Biochem Mol Biol 44:463-468
88. Tilson-Mallett N, Santner SJ, Feil PD, Santen RJ 1983 Biological significance of aromatase activity in human breast tumors. J Clin Endocrinol Metab 57:1125-1128
89. Santner SJ, Feil PD, Santen RJ 1984 In situ estrogen production via estrone sulfatase pathway in breast tumors: relative importance vs. the aromatase pathway. J Clin Endocrinol Metab 59:29-33
90. Utsumi T, Yoshimura N, Takeuchi S, Manila M, Maeda K, Harada N 2000 Elevated steroid sulfatase expression in breast cancer. J Steroid Biochem Mol Biol 73:141-145
91. Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde M, Talbi M, Maloche C 1996 Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81:1460-1464
92. Utsumi T, Yoshimura N, Takeuchi S, Ando J, Manila M, Maeda K, Harada N 1999 Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res 59: 377-381
93. Evans TRJ, Rowlands MG, Silva MC, Law M, Coombes RC 1993 Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer. J Steroid Biochem Mol Biol 44:583-587
94. Evans TRJ, Rowlands MG, Law M, Coombes RC 1994 Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. Br J Cancer 69:555-561
95. Miyoshi Y, Ando A, Hasegawa S, Ishitobi M, Taguchi T, Tamaki Y, Noguchi S 2003 High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. Clin Cancer Res 9:2288-2293
96. Silva MC, Rowlands MG, Dowsell M, Guslerson B, McKinna JA, Fryall L, Coombes RC 1989 Intratumoral aromatase as a prognostic factor in human breast carcinoma. Cancer Res 49:2588-2591
97. Liplon A, Sanlen RJ, Harvey HA, Sanders SL, Mathews YL 1992 Prognostic value of breast cancer aromatase. Cancer 70:1951-1955
98. Yoshimura N, Harada N, Bukholm I, Karesen R, Borresen-Dale A-L, Kristensen VN 2004 Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer. Breast Cancer Res 6:R46-R55
99. Purohit A, Ghilchik MW, Duncan LJ, Wang DY, Singh A, Walker MM, Reed MJ 1995 Aromatase activity and interleukin 6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 80:3052-3058
100. Sasano H, Nagura H, Harada N, Goukou Y, Kimura M 1994 Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol 25:530-535
101. Santen RJ, Martel J, Hoaland F, Naftolin F, Roa L, Harada N, Hafer L, Zaino R, Santner SJ 1994 Stromal spindle cells contain aromatase in human breast tumors. J Clin Endocrinol Metab 79: 627-632
102. Esteban JM, Warsi Z, Haniu M, Hull P, Shively JE, Chen S 1992 Detection of intratumoral aromatase in breast carcinomas. Am J Pathol 140:337-343
103. Vignon F, Terqui M, Westley B, Derocq D, Rochefort H 1980 Effects of plasma estrogen sulfates in mammary cancer cells. Endocrinology 106:1079-1086
104. Pasqualini JR, Gelly C, Lecerf F 1986 Estrogen sulfates: biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res Treat 8:233-240
105. Santner SJ, Levin MC, Santen RJ 1990 Estrone sulfate stimulates growth of nitrosomethylurea-induced breast carcinoma in vivo in the rat. Int J Cancer 46:73-78
106. Masamura S, Santner SJ, Santen RJ 1996 Evidence of in situ estrogen synthesis in nitrosomethylurea-induced rat mammary tumors via the enzyme estrone sulfatase. J Steroid Biochem Mol Biol 58:425-429
107. Reed MJ, Owen AM, Lai LC, Coldham NG, Ghilchik MW, Shaikh NA, James VHT 1989 In situ oestrone synthesis in normal breast and breast tumour tissue: effect of treatment with 4-hydroxyandrostenedione. Int J Cancer 44:233-237
108. James MR, Skaar TC, Lee RY, MacPherson A, Zwiebel JA, Ahluwalia BS, Ampy F, Clarke R 2001 Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo. Endocrinology 142:1497-1505
109. Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF 1999 DHEA and DHEAS: a review. J Clin Pharmacol 39:327-348
110. Rosenfeld RS, Rosenberg BJ, Fukushima DK, Hellman L 1975 Twenty four hour secretory pattern of dehydroepiandrosterone and dehydroepiandrosterone sulfate. J Clin Endocrinol Metab 40: 850-855
111. Bird CE, Masters V, Clark AF 1984 Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women. Clin Invest Med 7:119-122
112. Poortman J, Andriesse R, Agema A, Douker GH, Schwarz F, Thijssen JHH 1980 Adrenal androgen secretion and metabolism in postmenopausal women. In: Genazzani AR, Thijssen JHH, Siiteri PK, eds. Adrenal androgens. New York: Raven Press; 219-240
113. Bonney RC, Scanlon MJ, Reed MJ, Jones DL, Beranek PA, James VHT 1984 Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism. J Steroid Biochem 20:501-504
114. Adams JB, Garcia M, Rochefort H 1981 Estrogenic effects of physiological concentrations of 5-androst-3β, 17β-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Res 41:4720-4726
115. Poulin R, Labrie F 1986 Stimulation of cell proliferation and estrogenic response by adrenal C19-55-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46:4933-4937
116. Dauvois S, Labrie F 1989 Androstenedione and androst-5-ene-3β, 17β-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res Treat 13:61-69
117. Maggiolini M, Donze O, Jeannin E, Ando S, Picard D 1999 Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor α. Cancer Res 59:4864-4869
118. Le Bail JC, Lofti H, Charles L, Pepin D, Habrioux G 2002 Conversion of dehydroepiandrosterone sulfate at physiological plasma concentration into estrogen in MCF-7 cells. Steroids 67:1057-1064
119. Billich A, Nussbaumer P, Lehr P 2000 Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal sulfatase inhibitors. J Steroid Biochem Mol Biol 73:225-235
120. Morris KT, Toth-Fejel SE, Schmidt J, Fletcher WS, Pommier RF 2001 High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy. Surgery 130:947-953
121. Shapiro LJ, Weiss R, Webster D, France JT 1978 X-linked ichthyosis due to steroid sulphatase deficiency. Lancet 14:70-72
122. Hernandez-Martin A, Gonzalez-Sarmiento R, Unamuno P 1999 X-linked ichthyosis: an update. Br J Dermatol 141:617-627
123. Hoyer H, Lykkesfeldt G, Ibsen HH, Brandrup F 1986 Ichthyosis of steroid sulphatase deficiency. Clinical study of 76 cases. Dermatologica 172:184-190
124. Williams ML, Elias PM 1981 Stratum corneum lipids in disorders of cornification. J Clin Invest 68:1404-1410
125. Ballabio A, Shapiro LJ 1995 Steroid sulfatase and X-linked ichthyosis. In: Scriver CR, Beaudet AL, Sly WS, Vallee D, eds. The metabolic and molecular basis of inherited diseases. New York: McGraw-Hill; 2999-3022
126. Pitts RL 1987 Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J Am Acad Dermatol 16:571-573
127. Haning RV 1981 Using DHEAS to monitor androgen disorders. Contemp Obstet Gynecol 18:117-132
128. Hay JB, Hodgins MB 1973 Metabolism of androgens in vitro by human facial and axillary skin. J Endocrinol 59:475-486
129. Hoffman R 2001 Enzymology of the hair follicle. Eur J Dermatol 11:296-300
130. Hoffman R, Rot A, Niiyama S, Billich A 2001 Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Invest Dermatol 117:1342-1348
131. Chen WC, Thiboutot D, Zouboulis CC 2002 Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 119:992-1007
132. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D 1990 Regulation of murine lymphokine production in vivo. J Exp Med 171:979-996
133. Daynes RA, Dudley DJ, Araneo BA 1990 Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 20:793-803
134. Rook GAW, Hernandez-Pando R, Lightman S 1994 Hormones, peripherally activated hormones and regulation of Th1/Th2 balance. Immunol Today 15:301-303
135. Reed MJ, Purohit A, Singh A, Chander SK 2003 Androgenic modulation of the immune response. London: Parthenon Publishing Group
136. Watson R, Huls A, Araghinikuam M, Sangbun C 1996 Dehydroepiandrosterone and diseases of aging. Drugs Aging 9:274-291
137. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li G-Z, Ryu S-Y 1993 Altered regulation of IL-6 production with normal aging. J Immunol 150:5219-5230
138. Suitters AJ, Shaw S, Wales MR, Porter JR, Leonard J, Woodger R, Brand H, Bodmer M, Foulkes R1997 Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase. Immunology 91:314-321
139. Foulkes R, Shaw S, Suitters A 1997 Immunological consequences of inhibiting dehydroepiandrosterone sulfatase in vivo. In: Rook GAW, Lightman S, eds. Steroid hormones and the T-cell cytokine profile. London: Springer-Verlag; 135-152
140. Reed MJ 1995 The discriminant function test: a marker of Th1/Th2 cytokine secretion and breast tumour oestrogen synthesis. Mol Med Today 1:98-103
141. Reed MJ, Purohit A 1997 Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 18:701-715
142. Singh A, Purohit A, Duncan LJ, Mokbel K, Ghilchik MW, Reed MJ 1997 Control of aromatase in breast tumours: the role of the immune system. J Steroid Biochem Mol Biol 61:185-192
143. Siiteri PK, MacDonald PC 1973 Role of extraglandular estrogen in human endocrinology. In: Creep RO, Astwood EB, eds. Handbook of physiology, vol 2. Washington DC: American Physiological Society; 615-629
144. Wei J XH, Davies JL, Hemmings GP 1992 Increase of plasma IL-6 concentrations with age in healthy subjects. Life Sci 51:1953-1956
145. Orentreich N, Brind JL, Rijer RL, Vogelman JN 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59: 551-555
146. Corpechot C, Robel P, Axelson J, Sjovall J, Baulieu EE 1981 Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci USA 78:4704-4707
147. Mathur C, Prasad WK, Raju VS, Welch M, Lieberman S 1993 Steroids and their conjugates in the mammalian brain. Proc Natl Acad Sci USA 90:85-88
148. Park-Chung M, Malayev A, Purdy RH, Gibbs TT, Farb DH 1999 Sulfated and unsulfated steroids modulate γ-aminobutyric A receptor function through distinct sites. Brain Res 830:72-87
149. Fahey JM, Lindquist DG, Pritchard GA, Miller LG 1995 Pregnenolone sulfate potentiation of NMDA-mediated increases in intracellular calcium in cultured chick cortical neurons. Brain Res 69:183-188
150. Flood JF, Smith GE, Roberts E 1988 Dehydroepiandrosterone and its sulfate enhance memory retention in mice. Brain Res 447:269-278
151. Flood JF, Morely JE, Roberts E 1992 Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proc Natl Acad Sci USA 89:1567-1571
152. Reed MJ, Purohit A, Duncan LJ, Singh A, Roberts CJ, Williams GJ, Potter BVL 1995 The role of cytokines in regulating oestrogen synthesis in breast tumours. J Steroid Biochem Mol Biol 53:413-420
153. Li P-K, Rhodes ME, Jagannathan S, Johnson DA 1995 Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor esrrone-3-O- sulfamate. Brain Res Cogn Brain Res 2:251-254
154. Li P-K, Rhodes ME, Burke AM, Johnson DA 1996 Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine. Life Sci 60:45-51
155. Nicolas LB, Pinoteau W, Papot S, Routier S, Guillemet G, Mortand S 2001 Aggressive behaviour induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res 922:216-222
156. Roubertoux PL, Carlier M, Degrelle H, Haas-Dupertuis MC, Phillips J, Moutier R 1994 Co-segregation of inter-male aggression with the pseudosomal region of the Y chromosome in mice. Genetics 139:225-230
157. Le Roy I, Mortand S, Tordjman S, Donez-Darcel E, Carlier M, Degrelle H, Roubertoux PL 1999 Genetic correlation between steroid sulfatase concentration and initiation of attack behaviour in mice. Behav Genet 29:131-136
158. Warren JC, French AP 1965 Distribution of steroid sulfatase in human tissues. J Clin Endocrinol Metab 25:278-282
159. Manning RV, Hackett RJ, Boothroid RI, Canick JA 1990 Steroid sulfatase activity in the human ovarian corpus luteum, stroma and follicle: comparison to activity in other tissues and the placenta. J Steroid Biochem 36:175-179
160. Dehenin L, Jondet M, Scholler R 1987 Androgen and 19-norsteroid profiles in human preovulatory follicles from stimulated cycles: an isotope dilution mass spectroscopic study. J Steroid Biochem 26: 399-405
161. Adessi GL, Prost O, Agnani G, Petitjean A, Burnod J 1984 Estrone sulfatase activity in normal and abnormal endometrium. Arch Gynecol 236:13-18
162. Zhu BT, Fu JH 1997 Uterine estrogen sulfatase may play a more important role than hepatic sulfatase in mediating the uterotropic action of estrone-3-sulfate. Endocrine 7:191-198
163. Milewich L, Porter JC 1987 In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian and endometrial origin. J Clin Endocrinol Metab 65:164-169
164. Haning RV, Hackett RJ, Canick JA 1992 Steroid sulfatase in the human ovary and placenta: enzyme kinetics and phosphate inhibition. J Steroid Biochem Mol Biol 41:161-165
165. Martel C, Melner MH, Gagne D, Simard J, Labrie F 1994 Wide-spread distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/ δ5-4 isomerase, 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey. Mol Cell Endocrinol 104:103-111
166. Langlais J, Zollinger M, Plante L, Chapelelaine A, Bleau G, Roberts KD 1981 Localization of cholesteryl sulfate in human spermatozoa in support of a hypothesis for the mechanism of capacitation. Proc Natl Acad Sci USA 78:7266-7270
167. Huggins C, Scott WW 1945 Bilateral adrenalectomy in prostatic cancer. Ann Surg 122:1031-1041
168. Harper ME, Pike A, Peeling WB, Griffiths K 1974 Steroids of adrenal origin metabolized by human prostatic tissue in vivo and in vitro. J Endocrinol 60:117-125
169. Labrie F, Dupont A, Belanger A, Lacoursiere Y, Raynaud JP, Husson JM, Gareau J, Fazekas AT, Sandow J, Monfette G, Girard JG, Emond J, Houle JG 1983 New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgens. Prostate 4:579-594
170. Farnsworth WE 1973 Human prostatic dehydroepiandrosterone sulfate sulfatase. Steroids 21:647-664
171. Cowan RA, Cowan SK, Grant JK, Elder HY 1977 Biochemical investigations of separated epithelium and stroma from benign hyperplastic prostatic tissue. J Endocrinol 74:111-120
172. Klein H, Molwitz T, Bartsch W 1989 Steroid sulfatase in human benign prostatic hyperplasia: characterization and quantification of the enzyme in epithelium and stroma. J Steroid Biochem 33:195-200
173. Selcer KW, Kabler H, Sarap J, Xiao Z, Li P-K 2002 Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. Steroids 67:821-826
174. Riggs BL, Ryan RJ, Wahner HW, Jiang N, Mattox VR 1973 Serum concentrations of estrogen, testosterone and gonadotrophins in osteoporotic and non-osteoporotic postmenopausal women. J Clin Endocrinol Metab 36:1097-1099
175. Gooyer ME, Overlift GT, Kleyn V, Smits KC, Ederveen AGH, Verheul HAM, Kloosterboer HJ 2001 Tibolone: a compound with tissue specific inhibitory effects on sulfatase. Mol Cell Endocrinol 183:55-62
176. Kloosterboer HJ 1997 Tibolone and its metabolites: pharmacology, tissue specificity and effects in animal models of tumors. Gynecol Endocrinol 11(Suppl 1):63-68
177. Kloosterboer HL 2001 Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 76:231-238
178. Soliman HR, Dire D, Bondou P, Julien R, Launay J-M, Brerault J-L, Villette J-M, Fiet J 1993 Characterization of estrone sulfatase activity in human thrombocytes. J Steroid Biochem Mol Biol 46: 215-226
179. Epstein EH, Leventhal ME 1981 Steroid sulfatase of human leucocytes and epidermis and the diagnosis of recessive X-linked ichthyosis. J Clin Invest 67:1247-1262
180. Hirato K, Suzuki T, Hondo T, Saito H, Yanaihara T 1991 Steroid sulfatase activities in human leukocytes: biochemical and clinical aspects. Endocrinol Jpn 38:597-602
181. Kelly PM, Davison RS, Bliss E, McGee JO 1988 Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer 57:174-177
182. Reed MJ, Lai LC, Owen Am, Singh A, Coldham NG, Ghilchik MW, Shaikh NA, James VHT 1990 Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer Res 50:193-196
183. Purohit A, Froome VA, Wang DY, Potter BVL, Reed MJ 1997 Measurement of oestrone sulfatase activity in white blood cells to monitor in vivo inhibition of steroid sulphatase activity by oestrone-3-O-sulphamate. J Steroid Biochem Mol Biol 62:45-51
184. Purohit A, Riaz AA, Ghilchik MW, Reed MJ 1992 The origin of oestrone sulphate in normal and malignant breast tissues in post-menopausal women. Horm Metab Res 24:532-536
185. Hargenbuch B, Meier PJ 2003 The super family of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1-18
186. Jacquemin E, Hagenbuch R, Stieger B, Wolkoff AW, Meier PJ 1994 Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA 91:133-137
187. Noe IB, Hagenbuch R, Stieger B, Meier PJ 1997 Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA 94:10346-10350
188. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Herbert SC, Matsuno S, Kondo H, Yawo H 1998 Molecular characterization and tissue distribution of a new organic anion transporter subtype (OatpS) that transports thyroid hormones and taurocholate and comparison with Oarp2. J Biol Chem 273:22395-22401
189. Kullak-Ublick GA, Hagenbach B, Stieger B, Schteingart CD, Hoffman AF, Wolkoff AW, Meier PJ 1995 Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 109:1274-1282
190. Tamai I, Nezu J-I, Uchino H, Sai Y, Oku A, Shimane M TA 2000 Molecular identification and characterization of novel members of the human organic transporter (OATP) family. Biochem Biophys Res Comm 273:251-260
191. Pizzagalli F, Varga Z, Huber RD, Folkers G, Meier PJ, St-Pierre MV 2003 Identification of steroid sulfate transport processes in the human mammary gland. J Clin Endocrinol Metab 88:3902-3912
192. Tobacman JK, Hinkhouse M, Khalkhali-Ellis Z 2002 Steroid sulfatase activity and expression in mammary myoepithelial cells. J Steroid Biochem Mol Biol 81:65-68
193. Poirier D, Ciobanu LC, Maltais R1999 Steroid sulfatase inhibitors. Expert Opin Ther Patents 9:1083-1099
194. Nussbaumer P, Billich A 2003 Steroid sulfatase inhibitors. Med Res Rev 24:529-576
195. Smith HJ, Nicholls PJ, Simons C, LeLain R 2001 Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers. Exp Opin Ther Patents 11:789-824
196. Birnböck H, von Angerer E 1990 Sulfate derivatives of 2-phenylindoles as novel steroid sulfatase inhibitors. Biochem Pharmacol 39:1709-1713
197. Evans TRJ, Rowlands MG, Jarman M, Coombes RC 1991 Inhibition of estrone sulfatase enzyme in human placenta and human breast-carcinoma. J Steroid Biochem Mol Biol 39:493-499
198. Wong CK, Keung WM 1997 Daidzein sulfoconjugates are potent inhibitors of sterol sulfatase (EC 3.1.6.2). Biochem Biophys Res Commun 233:579-583
199. Anderson CJ, Lucas LJH, Widlanski TS 1995 Molecular recognition in biological systems: phosphate esters vs sulfate esters and the mechanism of action of steroid sulfatases. J Am Chem Soc 117: 3889-3890
200. Purohit A, Howarth NM, Potter BVL, Reed MJ 1994 Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer. J Steroid Biochem Mol Biol 48:523-527
201. Duncan L, Purohit A, Howarth NM, Potter BVL, Reed MJ 1993 Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate-a potential therapeutic agent in breast cancer. Cancer Res 53:298-303
202. Howarth NM, Cooper G, Purohit A, Duncan L, Reed MJ, Potter BVL 1993 Phosphonates and thiophosphonates as sulfate surrogates: synthesis of estrone 3-methylthiophosphonate, a potent inhibitor of estrone sulfatase. Bioorg Med Chem Lett 3:313-318
203. Howarth NM, Purohit A, Robinson JJ, Vicker N, Reed MJ, Potter BVL 2002 Estrone 3-sulfate mimics, inhibitors of estrone sulfatase activity; homology model construction and docking studies. Biochemistry 41:14801-14814
204. Howarth NM, Purohit A, Reed MJ, Potter BVL 1997 Estrone sulfonates as inhibitors of estrone sulfatase. Steroids 62:346-350
205. Li P-K, Pillai R, Dibbelt L 1995 Estrone sulfate analogs as estrone sulfatase inhibitors. Steroids 60:299-306
206. Li P-K, Pillai R, Young BL, Bender WH, Martino DM, Lin FT 1993 Synthesis and biochemical studies of estrone sulfatase inhibitors. Steroids 58:106-111
207. Dibbelt L, Li P-K, Pillai R, Knuppen R 1994 Inhibition of human placental sterylsulfatase by synthetic analogs of estrone sulfate. J Steroid Biochem Mol Biol 50:261-266
208. Anderson C, Freeman J, Lucas LH, Farley M, Dalhoumi H, Widlanski TS 1997 Estrone sulfatase: probing structural requirements for substrate and inhibitor recognition. Biochemistry 36:2586-2594
209. Howarth NM, Purohit A, Reed MJ, Potter BVL 1994 Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential. J Med Chem 37:219-221
210. Woo LWL, Purohit A, Reed MJ, Potter BVL 1997 Oestrone 3-O-(N-acetyl)sulphamate, a potential molecular probe of the active site of oestrone sulphatase. Bioorg Med Chem Lett 7:3075-3080
211. Woo LWL, Lightowler M, Purohit A, Reed MJ, Potter BVL 1996 Heteroatom-substituted analogues of the active site directed inhibitor estra-1,3,5(10)-trien-17-one-3-sulphamate inhibit estrone sulphatase by a different mechanism. J Steroid Biochem Mol Biol 57:79-88
212. Selcer KW, Jagannathan S, Rhodes ME, Li PK 1996 Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. J Steroid Biochem Mol Biol 59:83-91
213. Poirier D, Boivin RP 1998 17α-alkyl- or 17-α-substituted benzyl-17β-estradiols: a new family of estrone sulfatase inhibitors. Bioorg Med Chem Lett 8:1891-1896
214. Boivin RP, Luu-The V, Lachance R, Labrie F, Poirier D 2000 Structure-activity relationships of 17α-derivatives of estradiol as inhibitors of steroid sulfatase. J Med Chem 43:4465-4478
215. Boivin RP, Labrie F, Poirier D 1999 17α-Alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid sulfatase activity. Steroids 64:825-833
216. Ciobanu LC, Boivin RP, Luu-The V, Poirier D 2003 3β-Sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors. J Enzyme Inhib Med Chem 18:15-26
217. Chu GH, Peters A, Selcer KW, Li PK 1999 Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxy tamoxifen sulfamates. Bioorg Med Chem Lett 9:141-144
218. Golob T, Liebl R, von Angerer E 2002 Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells. Bioorg Med Chem 10:3941-3953
219. Jütten P, Schumann W, Härtl A, Heinisch L, Gräfe U, Werner W, Ulbricht H 2002 A novel type of nonsteroidal estrone sulfatase inhibitors. Bioorg Med Chem Lett 12:1339-1342
220. Nussbaumer P, Geyl D, Horvath A, Lehr P, Wolff B, Billich A 2003 Nortropinyl-arylsulfonylureas as novel, reversible inhibitors of human steroid sulfatase. Bioorg Med Chem Lett 13:3673-3677
221. Lee W, DeRome M, DeBear J, Noell S, Epstein D, Mahle C, DeCarr L, Woodruff K, Huang Z, Dumas J 2003 Aryl piperazines: a new class of steroid sulfatase inhibitors for the treatment of hormone-dependent breast cancer. J Abstr Papers Amer Chem Soc 226:301-Medi Part 2
222. Carlstrom K, Doberl A, Gershagen S, Rannevik G 1984 Peripheral plasma levels of dehydroepiandrosterone sulphate, dehydroepiandrosterone, androstenedione and testosterone following different doses of danazol. Acta Obstet Gynecol Scand 123(Suppl): 125-129
223. Chetrite G, Paris J, Botella J, Pasqualini JR 1996 Effect of nomegestrol acetate on estrone sulfatase and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells. J Steroid Biochem Mol Biol 58:525-531
224. Prost-Avallet O, Oursin J, Adessi GL 1991 In vitro effect of synthetic progestogens on estrone sulfatase activity in human breast carcinoma. J Steroid Biochem Mol Biol 39:967-973
225. Chetrite G, Kloosterboer HJ, Pasqualini JR 1997 Effect of tibolone (ORG OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells. Anticancer Res 17: 135-140
226. Santner SJ, Santen RJ 1993 Inhibition of estrone sulfatase and 17β-hydroxy steroid dehydrogenase by antiestrogens. J Steroid Biochem Mol Biol 45:383-390
227. Zhu BT, Kosh JW, Fu J-H, Cai MX, Xu S, Conney AH 2000 Strong inhibition of estrone-3-sulfatase activity by pregnenolone 16α-carbonitrile but not by several analogs lacking a 16α-nitrile group. Steroids 65:521-527
228. Elger W, Schwarz S, Hedden A, Reddersen G, Schneider B 1995 Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J Steroid Biochem Mol Biol 55:395-403
229. Purohit A, Vernon KA, Hummelinck AEW, Woo LWL, Hejaz HAM, Potter BVL, Reed MJ 1998 The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity. J Steroid Biochem Mol Biol 64:269-275
230. Purohit A, Hejaz HAM, Woo LWL, van Strien AE, Potter BVL, Reed MJ 1999 Recent advances in the development of steroid sulphatase inhibitors. J Steroid Biochem Mol Biol 69:227-238
231. Raobaikady B, Purohit A, Chander SK, Woo LWL, Leese MP, Potter BVL, Reed MJ 2003 Inhibition of MCF-7 breast cancer cell proliferation and in vivo steroid sulphatase activity by 2-methoxyoestradiol-bis-sulphamate. J Steroid Biochem Mol Biol 84: 351-358
232. Peters RH, Chao W-R, Sato B, Shigeno K, Zaveri NT, Tanabe M 2003 Steroidal oxathiazine inhibitors of estrone sulfatase. Steroids 68:97-110
233. Hejaz HAM, Purohit A, Mahon MF, Reed MJ, Potter BVL 1999 Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3/5(10)- estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)- estratriene. J Med Chem 42:3188-3192
234. Li P-K, Chu GH, Guo JP, Peters A, Selcer KW 1998 Development of potent non-estrogenic estrone sulfatase inhibitors. Steroids 63: 425-432
235. Ciobanu LC, Boivin RP, Luu-The V, Labrie F, Poirier D 1999 Potent inhibition of steroid sulfatase activity by 3-O-sulfamate of 17α-benzyl (or 4′-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and C17α of estradiol. J Med Chem 42:2280-2286
236. Ciobanu LC, Luu-The V, Poirier D 2002 Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors. J Steroid Biochem Mol Biol 80:339-353
237. Ciobanu LC, Luu-The V, Martel C, Labrie F, Poirier D 2003 Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase. Cancer Res 63:6442-6446
238. Ciobanu LC, Poirier D 2003 Solid-phase parallel synthesis of 17α-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker. J Comb Chem 5:429-440
239. Fischer DS, Chander SK, Woo LWL, Fenton JC, Purohit A, Reed MJ, Potter BVL 2003 Novel D-ring modified steroid derivatives as potent, non-estrogenic, steroid sulfatase inhibitors with in vivo activity. J Steroid Biochem Mol Biol 84:343-349
240. Li P-K, Milano S, Kluth L, Rhodes ME 1996 Synthesis and sulfatase inhibitory activities of non-steroidal estrone sulfatase inhibitors. J Steroid Biochem Mol Biol 59:41-48
241. Selcer KW, Hegde PV, Li P-K 1997 Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N- alkanoyl tyramines. Cancer Res 57:702-707
242. Chu G-H, Milano S, Kluth L, Rhodes M, Boni R, Johnson DA, Li P-K 1997 Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors. Steroids 62:530-535
243. Kolli A, Chu GH, Rhodes ME, Inoue K, Selcer KW, Li P-K 1999 Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors. J Steroid Biochem Mol Biol 68:31-40
244. Patel CK, Owen CP, Ahmed S 2003 The design, synthesis, and in vitro biochemical evaluation of a series of esters of 4-[(aminosulfonyl)oxy]benzoate as novel and highly potent inhibitors of estrone sulfatase. Biochem Biophys Res Commun 307:778-781
245. Woo LWL, Purohit A, Malini B, Reed MJ, Potter BVL 2000 Potent active site-directed inhibition of steroid sulfatase by tricyclic coumarin-based sulphamates. Chem Biol 7:773-791
246. Woo LWL, Purohit A, Reed MJ, Potter BVL 1996 Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates. J Med Chem 39:1349-1351
247. Woo LWL, Howarth NM, Purohit A, Hejaz HAM, Reed MJ, Potter BVL 1998 Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. J Med Chem 41:1068-1083
248. Purohit A, Woo LWL, Barrow D, Hejaz H, Nicholson RI, Potter BVL, Reed MJ 2001 Non-steroidal and steroidal sulfamates: new drugs for cancer therapy. Mol Cell Endocrinol 171:129-135
249. Malini B, Purohit A, Ganeshapillai D, Woo LWL, Potter BVL, Reed MJ 2000 Inhibition of steroid sulphatase activity by tricyclic coumarin sulphamates. J Steroid Biochem Mol Biol 75:253-258
250. Hejaz HAM 1998 The synthesis of steroidal and non-steroidal steroid sulphatase inhibitors for endocrine therapy of breast cancer, PhD thesis, University of Bath, Bath, United Kingdom
251. Nussbaumer P, Lehr P, Billich A 2002 2-Substituted 4-(thio)chromosome 6-O-sulfamates: potent inhibitors of human steroid sulfatase. J Med Chem 45:4310-4320
252. Nussbaumer P, Winiski AP, Billich A 2003 Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates, potent inhibitors of human steroid sulfatase. J Med Chem 46:5091-5094
253. Nussbaumer P, Bilban M, Billich A 2002 4,4′-Benzophenone-O, O′-disulfamate: a potent inhibitor of human steroid sulfatase. Bioorg Med Chem Lett 12:2093-2095
254. Hejaz HAM, Woo LWL, Purohit A, Reed MJ, Potter BVL 2004 Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulphatase. Bioorg Med Chem 12:2759-2772
255. Ahmed S, James K, Owen CP, Patel CK 2002 Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES). Bioorg Med Chem Lett 12:1343-1346
256. Fischer DS, Woo LWL, Mahon MF, Purohit A, Reed MJ, Potter BVL 2003 D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase. Bioorg Med Chem 11:1685-1700
257. Woo LWL, Sutcliffe OB, Bubert C, Grasso A, Chander SK, Purohit A, Reed MJ, Potter BVL 2003 First dual aromatase-sulfatase inhibitors. J Med Chem 46:3193-3196
258. Ahmed S, James K, Owen CP, Patel CK, Sampson L 2002 The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and aminosulfonate-based compounds. Bioorg Med Chem Lett 12:1279-1282
259. Purohit A, Williams GJ, Roberts CJ, Potter BVL, Reed MJ 1995 In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int J Cancer 63: 106-111
260. Purohit A, Woo LWL, Singh A, Winterborn CJ, Potter BVL, Reed MJ 1996 In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Cancer Res 56:4950-4955
261. Purohit A, Woo LWL, Potter BVL, Reed MJ 2000 In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667COUMATE. Cancer Res 60:3394-3396
262. Kellis JT, Vickery LE 1984 Inhibition of human estrogen synthase (aromatase) by flavones. Science 225:1032-10,34
263. Ibrahim AR, Abul-Hajj YJ 1990 Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol 37:257-260
264. Purohit A, Woo LWL, Chander SK, Newman SP, Ireson C, Ho Y, Grasso A, Leese MP, Potter BVL, Reed MJ 2003 Steroid sulphatase inhibitors for breast cancer. J Steroid Biochem Mol Biol 86:423-432
265. Kudoh M, Susaki Y, Ideyama Y, Nanya T, Okada M, Shikama H, Fujikura T 1995 The potent and selective inhibition of estrogen production by non-steroidal aromatase inhibitor, YM 511. J Steroid Biochem Mol Biol 54:265-271
266. Tominaga T, Suzuki T 2003 Early phase II study with new aromatase inhibitor YM 511 in postmenopausal patients with breast cancer. Difficulty in clinical dose recommendation based on preclinical and phase I findings. Anticancer Res 23:3533-3542
267. Patton TL, Dmochowski L 1963 Estrogens. V. Studies on the relationship of estrogenic activity and molecular structure. Arch Biochem Biophys 101:181-185
268. Dorfman RI, Kincl FA 1966 Uterotrophic activity of various phenolic steroids. Acta Endocrinol (Copenh) 52:619-626
269. Leese ML, Newman SP, Purohit A, Reed MJ, Potter BVL 2004 2-Alkylsulfanyl estrogen derivatives: synthesis of a novel class of multi-targeted anti-tumour agents. Bioorg Med Chem Lett 15:3135-3138
270. Seegers J, Aveling M-L, Van Aswegen CH, Cross M, Koch F, Joubert WS 1989 The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells. J Steroid Biochem 32:797-809
271. Pribluda VS, Gubish ER, La Vallee TM, Treston A, Swartz GM, Green S 2000 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 19: 173-179
272. Bradlow HL, Telang NT, Sepkovic DW, Osbourne MP 1996 2-Hydroxyestrone the 'good' estrogen. J Endocrinol 150:8259-8265
273. Zhu BT, Conney AH 1998 Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis. Cancer Res 58:2269-2277
274. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L 1994 The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368:237-239
275. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ 1997 Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 57:81-86
276. Purohit A, Hejaz HAM, Waiden L, MacCarthy-Morrogh L, Packham G, Potter BVL, Reed MJ 2000 The effect of 2-methoxyestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int J Cancer 85:584-589
277. MacCarthy-Morrogh L, Townsend PA, Purohit A, Hejaz HAM, Potter BVL, Reed MJ, Packham G 2000 Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis and microtubule assembly in human breast cancer cells. Cancer Res 60:5441-5450
278. Ireson C, Chander SK, Purohit A, Perera S, Newman SP, Parish D, Leese MP, Smith AC, Potter BVL, Reed MJ 2004 Pharmacokinetics and efficacy of 2-methoxyestradiol and 2-methoxyestradiol-bis-sulphamate in vivo in rodents. Br J Cancer 90:932-937
279. Ho YT, Purohit A, Vicker N, Newman SP, Robinson JJ, Leese ML, Ganeshapillai D, Woo LWL, Potter BVL, Reed MJ 2003 Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates. Biochem Biophys Res Commun 305:909-914
280. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS 2002 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β. Cancer Res 62:3691-3697
281. Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P 2003 2-ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3:363-375
282. Singh A, Purohit A, Hejaz HAM, Potter BVL, Reed MJ 2000 Inhibition of deoxyglucose uptake in MCF-7 breast cancer cells by 2-methoxyestrone and 2-methoxyestrone-3-O-sulfamate. Mol Cell Endocrinol 160:61-66
283. Newman SP, Leese MP, Purohit A, James DRC, Rennie CE, Potter BVL, Reed MJ 2004 Inhibition of in vitro angiogenesis by 2-methoxy- and 2-ethyl-estrogen sulfamates. Int J Cancer 109:533-540
284. Lobo RA, Cassidenti DL 1992 Pharmacokinetics of oral 17β-estradiol. J Reprod Med 37:77-84
285. Mashchak CA, Lobo RA, Dozono-Takano R, Eggena P, Nakamura RM, Brenner PF, Mishell DR 1982 Comparison of the pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 144:511-518
286. Elger W, Barth A, Hedden A, Reddersen G, Ritter P, Schneider B, Zuchner J, Krahl E, Muller K, Oettel M, Schwarz S 2001 Estrogen sulfamates: a new approach to oral estrogen therapy. Reprod Fertil Dev 13:297-305
287. Ireson CR, Parish D, Purohit A, Woo LWL, Potter BVL, Chander SK, Reed MJ 2003 Development of a sensitive high-performance liquid chromatography method for the detection of 667 COUMATE in vivo. J Steroid Biochem Mol Biol 84:337-342
288. Lin JH, Lin TH, Cheng H 1992 Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro. Pharm Res 9:339-344
289. Racacha R, Costanzo MJ, Maryanoff BE, Chattopadhyay D 2002 Crystal structure of human carbonic anhydrase II with an anticonvulsant sugar sulphamate. Biochem J 361:437-441
290. Vicker N, Ho YT, Robinson J, Woo LWL, Purohit A, Reed MJ, Potter BVL 2003 Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorg Med Chem Lett 13:863-865
291. Abbate F, Winum J-Y, Potter BVL, Casini A, Montera J-L, Scozzafava A, Supuran CT 2004 Carbonic anhydrase inhibitors: x ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase. Bioorg Med Chem Lett 14:231-234
292. Sly WS, Hu PY 1995 Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 64:375-401
293. McKierman JM, Buttyan R, Stifelman MD, Katz AE, Chen MW, Olsson CA, Sawczuk IS 1997 Expression of tumor-associated gene MN: a potential biomarker of human renal cell carcinoma. Cancer Res 57:2362-2365
294. Tureci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila A-K, Shah GN, Grubb JH, Pfreundschuh M, Sly WS 1998 Human carbonic anhydrase XII: cDNA cloning, expression and chromosomal localization of a carbonic anhydrase gene that is over expressed in some renal cancers. Proc Natl Acad Sci USA 95:7608-7613
295. Potter CPS, Harris AL 2003 Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 89:2-7
296. Loncaster JA, Harris AL, Davison SE, Logue JP, Hunter RD, Wycoff CC, Pastorek J, Ratcliffe PJ, Stratford IJ, West CML 2001 Carbonic anhydrase IX expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61:6394-6399
297. Harris AL 2001 Hypoxia-a key regulatory factor in tumour growth. Nat Cancer Rev 2:38-47
298. Koukourakis MI, Giatromanolaki A, Siuridis E, Simopoulos K, Pastorek J, Harris AL 2001 Hypoxia-regulated carbonic anhydrase-9 relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res 7:3399-3403
299. Whittington DA, Waheed A, Ulmasov B, Shah GN, Grubb JH, Sly WS, Christianson DW 2001 Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein over expressed in certain cancer tumor cells. Proc Natl Acad Sci USA 98:9545-9550
300. Winum J-Y, Vullo D, Casini A, Montero J-L, Scozzafava A, Supuran CT 2003 Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors. J Med Chem 46:2197-2204
301. Parkkila S, Rajaniemi H, Parkkila A-K, Kivela J, Waheed A, Pastorekova S, Pastorek J, Sly WS 2000 Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 97:2220-2224
302. Teicher BA, Liu S-D, Liu J-T, Holden SA, Herman TS 1993 A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549-1556
303. Purohit A, Potter BVL, Parker MG, Reed MJ 1998 Steroid sulphatase: expression, isolation and inhibition for active-site identification studies. Chem Biol Interact 109:183-193
304. Hernandez-Guzman FG, Higashiyama T, Osawa Y, Ghosh D 2001 Purification, characterization and crystallisation of human placental estrone/ dehydroepiandrosterone sulfatase, a membrane-bound enzyme of the endoplasmic reticulum. J Steroid Biochem Mol Biol 78:441-450
305. Hernandez-Guzman FG, Higashiyama T, Pangborn W, Osawa Y, Ghosh D 2003 Structure of human estrone sulfatase suggests functional roles of membrane association. J Biol Chem 278:22989-22997
306. Lukatela G, Krauss N, Theis K, Selmer T, Gieselmann V, von Figura K, Saenger W 1998 Crystal structure of human aryl-sulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfatase ester hydrolysis. Biochemistry 37:3654-3664
307. Schmidt B, Seimer T, Ingendoh A, von Figura K 1995 A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell 82:271-278
308. Dierks T, Schmidt B, von Figura K 1997 Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum. Proc Natl Acad Sci USA 94:11963-11986
309. Selmer T, Hallmann A, Schmidt B, Sumper M, von Figura K 1996 The evolutionary conservation of a novel protein modification, the conversion of cysteine to serine-semialdehyde in arylsulfatase from Volvox carteri. Eur J Biochem 238:341-345
310. Recksiek M, Selmer T, Dierks T, Schmidt B, von Figura K 1998 Sulfatases, trapping of the sulphated enzyme intermediate by substituting the active site formylglycine. J Biol Chem 273:6096-6103
311. Sahm UG, Williams GJ, Purohit A, Hidalgo Aragones MI, Parish D, Reed MJ, Potter BVL, Poulton CW 1996 Development of an oral formulation for oestrone 3-O-sulphamate, a potent sulphatase inhibitor. Pharm Sci 2:17-20
312. Williams A, Douglas KT 1974 Hydrolysis of aryl N-methylaminosulphonates: evidence consistent with an E1cB mechanism. J Chem Soc Perkins Trans 2:1727-1732
313. Spillane WJ, Hogan G, McGrath P, King J, Brack C 1996 Aminolysis of sulfamate esters in non-aqueous solvents. Evidence consistent with a concerted E2-type mechanism. J Chem Soc Perkins Trans 2:2099-2104
314. Purohit A, Williams GA, Howarth NM, Potter BVL, Reed MJ 1995 Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O- sulfamate. Biochemistry 34:11508-11514
315. Waldow A, Schmidt B, Dierks T, von Bülow R, von Figura K 1999 Amino acid residues forming the active site of arylsulfatase A: role in catalytic activity and substrate binding. J Biol Chem 274:12284-12288
316. Fersht A 1984 The pH dependence of enzyme catalysis. In: Enzyme structure and mechanism. Chap 5. New York: W. H. Freeman and Co.; 156
317. Stanway S, Purohit A, Woo LWL, Sufi S, Dobbs N, Elliot M, Potter BVL, Reed MJ, Coombes RC 2004 First phase I trial of a steroid sulfatase inhibitor in breast cancer. J Clin Oncol 22 (Suppl 14S) Abstract 64S
318. Zaveri NT, Chao W-R, Peters R, Tanabe M, Yamada Y, Toko T, Asao T, Eshima K A novel dual-targeted approach for the endocrine therapy and prevention of breast cancer: SR 16158, a novel steroid sulfatase inhibitor/tissue-selective antiestrogen. Proc American Association for Cancer Research, Advances in Breast Cancer Res, Huntingdon Beach, CA, 2003 (Abstract B25)